Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy

Nariman Nezami, Javid Safa, Amir Taher Eftekhar-Sadat, Behzad Salari, Sona Ghorashi, Khashayar Sakhaee, Khashayar Khosraviani

Research output: Contribution to journalArticle

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)1294-1299
Number of pages6
JournalClinical Biochemistry
Volume43
Issue number16-17
DOIs
StatePublished - Nov 2010

    Fingerprint

Keywords

  • Diabetes
  • HMG-CoA reductase inhibitors
  • Lovastatin
  • Nephropathy
  • Osteoprotegerin
  • RANK ligand

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Nezami, N., Safa, J., Eftekhar-Sadat, A. T., Salari, B., Ghorashi, S., Sakhaee, K., & Khosraviani, K. (2010). Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. Clinical Biochemistry, 43(16-17), 1294-1299. https://doi.org/10.1016/j.clinbiochem.2010.08.012